Crafting a Career as a Woman in Video & Film

 

The industry of video production seems synonymous with bearded, tattooed, long-haired men toting cameras and talking gear shop. But there are women working behind the lens. Though still a minority, women working in film production is on the rise. Daniel Litwin talks to two female video professionals to get a first-person perspective on being a woman in the industry on this episode of Marketscale Creates.

Jessie Anderson-Berens, Owner, Videographer and Producer at Palmetto Coast Media and Palmetto Wedding Films has been in the film industry since 2004. At the start of her career, there were hardly any other women to be found. But today, with the help of social media and a vast network, Jessie surrounds herself with a positive team and a community of passionate Charleston-based video professionals. Her two companies, Palmetto Coast Media and Palmetto Wedding Films, fulfill all production needs, be it TV programs, business promos, nonprofits, events or wedding videos.

Beverly Tan, Founder and Storyteller at Fire & Spunk Productions, has recently graduated into a new era of film production and has found the Facebook community of female media professionals to be invaluable in offering camaraderie and job opportunities. With her eye on TV and Film, Tan is always on the hunt for good stories that have drama and intrigue.

“Filmmaking is the most collaborative art form there is,” said Tan in a nod to the many different shoes the women have filled throughout their careers. Both Andersen-Berens and Tan’s experience shows they do more on the set than “show up and shoot.” Be it as a CEO, producer, or freelancer, the women have both had storied careers. They prove to be not just good female filmmakers, but good filmmakers. Call it a woman’s touch or simply sublime filmmaking, their work resonates deeply with viewers, no matter the genre.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More